Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gouin

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
La Revue De Medecine Interne|December 31, 2013
[Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older]É Pautas, I Peyron, I Gouin-Thibault, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2015
Multimodal assessment of non-specific hemostatic agents for apixaban reversalA-C Martin, I Gouin-Thibault, V Siguret, et al.
Thrombosis Research|November 5, 2002
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.
Journal De Medecine Vasculaire|June 24, 2020
Impact of multidisciplinary team meetings on the management of venous thromboembolism. A clinical study of 142 casesC Mauger, I Gouin, P Guéret, et al.
Annales De Biologie Clinique|October 19, 2005
[Plasma cell leukaemia]C Rodriguez, J-C Pont, I Gouin-Thibault, et al.
Annales Francaises D'Anesthesie Et De Reanimation|August 9, 2011
[Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors]P Sié, C-M Samama, A Godier, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2016
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycinI Gouin-Thibault, X Delavenne, A Blanchard, et al.
Thrombosis Journal|September 14, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryM Hardy, T Lecompte, J Douxfils, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2011
Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypesC Moreau, E Pautas, I Gouin-Thibault, et al.
La Revue De Medecine Interne|December 31, 2013
[Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older]É Pautas, I Peyron, I Gouin-Thibault, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2015
Multimodal assessment of non-specific hemostatic agents for apixaban reversalA-C Martin, I Gouin-Thibault, V Siguret, et al.
Thrombosis Research|November 5, 2002
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutationI Gouin-Thibault, R Arkam, S Nassiri, et al.
Journal De Medecine Vasculaire|June 24, 2020
Impact of multidisciplinary team meetings on the management of venous thromboembolism. A clinical study of 142 casesC Mauger, I Gouin, P Guéret, et al.
Annales De Biologie Clinique|October 19, 2005
[Plasma cell leukaemia]C Rodriguez, J-C Pont, I Gouin-Thibault, et al.
Annales Francaises D'Anesthesie Et De Reanimation|August 9, 2011
[Surgery and invasive procedures in patients on long-term treatment with oral direct thrombin or factor Xa inhibitors]P Sié, C-M Samama, A Godier, et al.
Journal of Thrombosis and Haemostasis : JTH|November 29, 2016
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycinI Gouin-Thibault, X Delavenne, A Blanchard, et al.
Thrombosis Journal|September 14, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryM Hardy, T Lecompte, J Douxfils, et al.
Clinical Pharmacology and Therapeutics|October 2, 2009
Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatientsE Pautas, C Moreau, I Gouin-Thibault, et al.
Pageof 3